Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Wrzesinski

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|July 27, 2012
Radiotherapy plus chemotherapy in muscle-invasive bladder cancerCarl D Atkins, Stephen H Wrzesinski
Clinics in Liver Disease|June 22, 2011
Systemic therapy in hepatocellular carcinomaStephen H Wrzesinski, Tamar H Taddei, Mario Strazzabosco
Experimental Hematology & Oncology|March 19, 2013
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivoStephen H Wrzesinski, Jan L Fisher, Marc S Ernstoff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Transforming growth factor-beta and the immune response: implications for anticancer therapyStephen H Wrzesinski, Yisong Y Wan, Richard A Flavell
Nature Reviews. Immunology|July 10, 2010
The polarization of immune cells in the tumour environment by TGFbetaRichard A Flavell, Shomyseh Sanjabi, Stephen H Wrzesinski, et al.
Orbit (Amsterdam, Netherlands)|October 10, 2022
Emerging therapeutic options for periorbital and orbital cutaneous basal and squamous cell carcinomasEdward J Wladis, Stephen H Wrzesinski, Michael I Rothschild, et al.
Expert Opinion on Biological Therapy|April 7, 2009
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapyErin R Steenblock, Stephen H Wrzesinski, Richard A Flavell, et al.
Anti-Cancer Drugs|September 1, 2007
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfateStephen H Wrzesinski, Meghan L McGurk, Constance T Donovan, et al.
Journal of Neuro-Oncology|October 26, 2005
Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomasStephen H Wrzesinski, Konstantin H Dragnev, Lorna K Mayo, et al.
Human Gene Therapy|November 26, 2008
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytesPeter M Rabinovich, Marina E Komarovskaya, Stephen H Wrzesinski, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|July 27, 2012
Radiotherapy plus chemotherapy in muscle-invasive bladder cancerCarl D Atkins, Stephen H Wrzesinski
Clinics in Liver Disease|June 22, 2011
Systemic therapy in hepatocellular carcinomaStephen H Wrzesinski, Tamar H Taddei, Mario Strazzabosco
Experimental Hematology & Oncology|March 19, 2013
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivoStephen H Wrzesinski, Jan L Fisher, Marc S Ernstoff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Transforming growth factor-beta and the immune response: implications for anticancer therapyStephen H Wrzesinski, Yisong Y Wan, Richard A Flavell
Nature Reviews. Immunology|July 10, 2010
The polarization of immune cells in the tumour environment by TGFbetaRichard A Flavell, Shomyseh Sanjabi, Stephen H Wrzesinski, et al.
Orbit (Amsterdam, Netherlands)|October 10, 2022
Emerging therapeutic options for periorbital and orbital cutaneous basal and squamous cell carcinomasEdward J Wladis, Stephen H Wrzesinski, Michael I Rothschild, et al.
Expert Opinion on Biological Therapy|April 7, 2009
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapyErin R Steenblock, Stephen H Wrzesinski, Richard A Flavell, et al.
Anti-Cancer Drugs|September 1, 2007
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfateStephen H Wrzesinski, Meghan L McGurk, Constance T Donovan, et al.
Journal of Neuro-Oncology|October 26, 2005
Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomasStephen H Wrzesinski, Konstantin H Dragnev, Lorna K Mayo, et al.
Human Gene Therapy|November 26, 2008
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytesPeter M Rabinovich, Marina E Komarovskaya, Stephen H Wrzesinski, et al.
Pageof 2